Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver.
about
Getting the balance right: Established and emerging therapies for major depressive disordersCitalopram--a review of pharmacological and clinical effects.Biotransformation of xenobiotics by amine oxidases.Enantiomeric antidepressant drugs should be considered on individual merit.Human liver aldehyde oxidase: inhibition by 239 drugs.PharmGKB summary: citalopram pharmacokinetics pathway.Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected?Escitalopram for the treatment of major depression and anxiety disorders.The pharmacokinetics of escitalopram in patients with hepatic impairment.Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.Aldehyde oxidase and its importance in novel drug discovery: present and future challenges.Profiling substrate specificity of two series of phenethylamine analogs at monoamine oxidase A and B.Interaction of psychotropic drugs with monoamine oxidase in rat brain.In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations.Citalopram has an antagonistic action on cortical spreading depression in well-nourished and early-malnourished adult rats.Inhibitory effects of flavonoids on aldehyde oxidase activity
P2860
Q24610225-C7D70CA9-E702-4185-87CB-9CE353BB02EBQ33948515-82E4EAA5-2909-46E6-85AD-968D4EDD2C26Q34316455-0246E4E4-8C70-4E10-A4D0-D8D708FBC08EQ34982628-64EAB905-94F4-4405-8F3A-59029D491102Q35610000-F05136B6-0445-484E-86B7-2251CFA2B711Q35952370-6665E008-028D-47D9-BC27-7100755C6CF7Q36662870-6963EFF3-B575-4AAD-AF33-32A8F4095400Q36941961-239DB8A1-5A38-4600-AD13-34AD472A5B5FQ37139768-4063F8C9-D9B0-437C-AFA9-544DE98F546CQ37361919-A176A08D-5992-4EB5-A01C-715D4F7084B8Q37928965-6879AEE8-A0AE-443E-983D-82F3851416C3Q38097076-8C7C012C-EF88-4E06-B130-760CD6F80AC2Q39123651-907840BA-5D87-4D53-AA36-E16FADEC252BQ43716409-E53CE370-C285-4EAF-9632-3A8D5C5B070AQ43882785-D0296F20-20A5-488D-B648-9B39A6657EA3Q43986188-76D06621-CBDB-41B9-8B9F-95F146BA2424Q57100609-466106F0-28F1-4B88-8C57-7CC4E8C50C6F
P2860
Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Stereoselective biotransformat ...... amine oxidases in human liver.
@en
Stereoselective biotransformat ...... amine oxidases in human liver.
@nl
type
label
Stereoselective biotransformat ...... amine oxidases in human liver.
@en
Stereoselective biotransformat ...... amine oxidases in human liver.
@nl
prefLabel
Stereoselective biotransformat ...... amine oxidases in human liver.
@en
Stereoselective biotransformat ...... amine oxidases in human liver.
@nl
P2093
P1476
Stereoselective biotransformat ...... amine oxidases in human liver.
@en
P2093
P356
10.1016/S0006-2952(98)00008-2
P407
P577
1998-07-01T00:00:00Z